These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 31193787)
1. Histologically benign metastasizing tenosynovial giant cell tumor mimicking metastatic malignancy: A case report and review of literature. Chen EL; de Castro CM; Hendzel KD; Iwaz S; Kim MA; Valeshabad AK; Shokouh-Amiri M; Xie KL Radiol Case Rep; 2019 Aug; 14(8):934-940. PubMed ID: 31193787 [TBL] [Abstract][Full Text] [Related]
2. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints. Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236 [TBL] [Abstract][Full Text] [Related]
3. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Abdul-Karim FW; el-Naggar AK; Joyce MJ; Makley JT; Carter JR Hum Pathol; 1992 Jul; 23(7):729-35. PubMed ID: 1319390 [TBL] [Abstract][Full Text] [Related]
4. Multiple metastases from histologically benign intraarticular diffuse-type tenosynovial giant cell tumor: a case report. Asano N; Yoshida A; Kobayashi E; Yamaguchi T; Kawai A Hum Pathol; 2014 Nov; 45(11):2355-8. PubMed ID: 25130396 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy. Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158 [TBL] [Abstract][Full Text] [Related]
6. Metastasizing tenosynovial giant cell tumour, diffuse type/pigmented villonodular synovitis. Righi A; Gambarotti M; Sbaraglia M; Frisoni T; Donati D; Vanel D; Dei Tos AP Clin Sarcoma Res; 2015; 5():15. PubMed ID: 26052431 [TBL] [Abstract][Full Text] [Related]
8. MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response assessment. Spierenburg G; Suevos Ballesteros C; Stoel BC; Navas Cañete A; Gelderblom H; van de Sande MAJ; van Langevelde K Insights Imaging; 2023 Feb; 14(1):22. PubMed ID: 36725759 [TBL] [Abstract][Full Text] [Related]
9. Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Somerhausen NS; Fletcher CD Am J Surg Pathol; 2000 Apr; 24(4):479-92. PubMed ID: 10757395 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle. Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900 [TBL] [Abstract][Full Text] [Related]
11. The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life. Mastboom MJ; Planje R; van de Sande MA Interact J Med Res; 2018 Feb; 7(1):e4. PubMed ID: 29475829 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cassier PA; Gelderblom H; Stacchiotti S; Thomas D; Maki RG; Kroep JR; van der Graaf WT; Italiano A; Seddon B; Dômont J; Bompas E; Wagner AJ; Blay JY Cancer; 2012 Mar; 118(6):1649-55. PubMed ID: 21823110 [TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology diagnosis of metastatic malignant diffuse type tenosynovial giant cell tumor. Ramteke P; Iyer VK; Madan K; Gamangatti S; Mridha AR J Cytol; 2017; 34(3):174-176. PubMed ID: 28701836 [TBL] [Abstract][Full Text] [Related]
14. Image-guided, intensity-modulated radiotherapy for the treatment of diffuse-type tenosynovial giant cell tumor of the knee: Case report and review of the literature. Xiang X; Jiang W; Qiu C; Xiao N; Liang J Medicine (Baltimore); 2021 Jul; 100(28):e26659. PubMed ID: 34260572 [TBL] [Abstract][Full Text] [Related]
15. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Ravi V; Wang WL; Lewis VO Curr Opin Oncol; 2011 Jul; 23(4):361-6. PubMed ID: 21577109 [TBL] [Abstract][Full Text] [Related]
16. Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee with Concurrent Polymicrobial Infection ( Marshall JH; Skedros JG; Campana CF; Seibert AM Case Rep Infect Dis; 2021; 2021():5523212. PubMed ID: 34557317 [TBL] [Abstract][Full Text] [Related]
17. Bone Involvement Mimicking an Aggressive Bone Lesion in a Diffuse-type Tenosynovial Giant Cell Tumor in the Thoracic Vertebral Lamina: A Case Report. Sakamoto A; Matsuyama A; Hisaoka M; Matsuda S J Orthop Case Rep; 2018; 8(3):14-17. PubMed ID: 30584508 [TBL] [Abstract][Full Text] [Related]
18. Giant Cell Tumor in Tarsal Midfoot Bones: A Case Report. Abed Alharbi W; Mohammed Alshareef H; Hennawi YB; Munshi AA; Khalid Alzahrani A Cureus; 2024 Mar; 16(3):e56215. PubMed ID: 38623116 [TBL] [Abstract][Full Text] [Related]
19. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors. Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409 [TBL] [Abstract][Full Text] [Related]
20. Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases. Mastboom MJL; Verspoor FGM; Gelderblom H; van de Sande MAJ Case Rep Orthop; 2017; 2017():7402570. PubMed ID: 28744388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]